Net Cash Provided by (Used in) Financing Activities of BioCardia, Inc. from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BioCardia, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • BioCardia, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $196,000, a 86% decline year-over-year.
  • BioCardia, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9,300,000, a 150% increase from 2023.
  • BioCardia, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3,726,000, a 27% decline from 2022.
  • BioCardia, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $5,122,000, a 163% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BioCardia, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $196,000 -$1,180,000 -86% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $1,376,000 +$1,312,000 +2050% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $64,000 +$64,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $0 -$2,005,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $2,005,000 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q1 2018 $5,000 -$17,000 -77% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $22,000 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2012 $0 -$724,000 -100% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q1 2011 $724,000 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1

BioCardia, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $9,300,000 +$5,574,000 +150% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $3,726,000 -$1,396,000 -27% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $5,122,000 +$3,175,000 +163% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $1,947,000 -$26,264,000 -93% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $28,211,000 +$18,393,000 +187% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $9,818,000 +$6,014,000 +158% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $3,804,000 +$3,660,000 +2542% 01 Jan 2018 31 Dec 2018 10-K 09 Apr 2020 2019 FY
2017 $144,000 -$4,252,000 -97% 01 Jan 2017 31 Dec 2017 10-K 09 Apr 2020 2019 FY
2016 $4,396,000 -$3,125,000 -42% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2019 2018 FY
2015 $7,521,000 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
2012 $0 +$500,000 01 Jan 2012 31 Dec 2012 10-K 22 Mar 2013 2012 FY
2011 $500,000 -$1,000,000 -200% 01 Jan 2011 31 Dec 2011 10-K 22 Mar 2013 2012 FY
2010 $500,000 01 Jan 2010 31 Dec 2010 10-K 29 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.